September 1, 2011 | By Ashley Post
The high court's Pliva v. Mensing decision shields generic-medication companies from failure-to-warn claims.
Most Popular Articles
From Deloitte Discovery
From Merrill DataSite
From Copyright Clearance Center
From Bloomberg BNA
March 26, 2014 at 2:00 pm ET
March 17, 2014 at 1:00 pm ET
Get the latest business trends, current corporate litigation, labor developments, technology initiatives and more.
Sign up to receive InsideScoop — FREE
You have been subscribed! You will receive a confirmation email soon.